Drug Database · Clinicians

Calcitriol + Minerals

Brands (1) D-CalShow all

Vitamin and minerals PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: INDICATIONS AND USAGE Predialysis Patients Calcitriol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr… US FDA label

    Kidney dosing: Calcitriol (single-agent)
    Show full dosing details
    eGFR ≥60
    No CKD indication at this level in the label.
    eGFR 30–59
    Predialysis secondary hyperparathyroidism (label: Ccr 15 to 55): start 0.25 mcg/day; may increase to 0.5 mcg/day. KDIGO 2017: not routinely used in G3a–G5 non-dialysis; reserve for G4–G5 with severe, progressive hyperparathyroidism.
    eGFR 15–29
    Predialysis: start 0.25 mcg/day; may increase to 0.5 mcg/day (label). KDIGO 2017: not routinely used in G3a–G5 non-dialysis; reserve for G4–G5 with severe, progressive hyperparathyroidism.
    eGFR <15 (not on dialysis)
    Label indication covers Ccr 15 to 55; below 15 not on dialysis is not addressed. Specialist input.
    Hemodialysis (intermittent)
    Start 0.25 mcg/day; increase by 0.25 mcg/day every 4 to 8 weeks; check calcium at least twice weekly during titration. Most hemodialysis patients respond to 0.5 to 1 mcg/day (label).
    Peritoneal dialysis
    Dialysis-patient dosing as above applies (label lists dialysis without modality restriction). Calcium-free dialysate PD has been used for hypercalcemia (label).
    CRRT
    Not addressed in label.
    • Dialyzable? Not stated. Hypercalcemia in dialysis patients can be corrected by dialysis against a calcium-free dialysate (label).
    • Monitoring Serum calcium at least twice weekly during titration; phosphorus, magnesium, alkaline phosphatase periodically; stop if hypercalcemia until normocalcemia (label). Intact PTH periodically; stop if PTH normalizes (label) and avoid oversuppression. Follow KDIGO CKD-mineral and bone disorder (CKD-MBD) targets.

    From the Calcitriol monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Softgel capsule

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Calcitriol + Minerals as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Calcitriol + Minerals
Package insert
D-CalMinerals + Calcitriol
Softgel Capsule (See Reverse for Formulation Details)Alu/Amber PVC Blister Pack x 10's (Box of 30's)
Rx
Capsulation and Pharmaceuticals (P) Ltd.India
Eon Pharmatek, Inc.Trader: Regenix Drugs Ltd.
DR-XY40901
May 17, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .